Registration Strip Icon for discussion 같은 생각을 가진 투자자들과 토론할 수 있는 활발한 포럼에서 상호 작용하려면 등록하세요.

AVDL

Avadel Pharmaceuticals (AVDL)

Avadel Pharmaceuticals PLC
일자:
정렬 기준:
 검색 관련기사 보기:NASDAQ:AVDL
일자시간출처헤드라인심볼기업
2024/08/0822:25Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:AVDLAvadel Pharmaceuticals PLC
2024/08/0820:12Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:AVDLAvadel Pharmaceuticals PLC
2024/08/0820:00GlobeNewswire Inc.Avadel Pharmaceuticals Provides Corporate Update and Reports Second Quarter 2024 Financial ResultsNASDAQ:AVDLAvadel Pharmaceuticals PLC
2024/08/0205:38Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AVDLAvadel Pharmaceuticals PLC
2024/08/0205:37Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AVDLAvadel Pharmaceuticals PLC
2024/08/0205:36Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AVDLAvadel Pharmaceuticals PLC
2024/08/0205:35Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AVDLAvadel Pharmaceuticals PLC
2024/08/0205:32Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AVDLAvadel Pharmaceuticals PLC
2024/08/0205:31Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AVDLAvadel Pharmaceuticals PLC
2024/08/0205:13Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:AVDLAvadel Pharmaceuticals PLC
2024/08/0121:00GlobeNewswire Inc.Avadel Pharmaceuticals to Provide a Corporate Update and Report Second Quarter 2024 Financial Results on August 8NASDAQ:AVDLAvadel Pharmaceuticals PLC
2024/08/0105:48Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:AVDLAvadel Pharmaceuticals PLC
2024/08/0105:05GlobeNewswire Inc.Avadel Pharmaceuticals Announces First Patient Dosed in Phase 3 REVITALYZ™ Trial of LUMRYZ™ (sodium oxybate) Extended-Release Oral Suspension for the Treatment of Idiopathic HypersomniaNASDAQ:AVDLAvadel Pharmaceuticals PLC
2024/06/2805:05GlobeNewswire Inc.Avadel Pharmaceuticals to Join Russell 3000® IndexNASDAQ:AVDLAvadel Pharmaceuticals PLC
2024/06/1820:25Edgar (US Regulatory)Form ARS - Annual Report to Security HoldersNASDAQ:AVDLAvadel Pharmaceuticals PLC
2024/06/1820:17Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:AVDLAvadel Pharmaceuticals PLC
2024/06/1820:11Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:AVDLAvadel Pharmaceuticals PLC
2024/05/3021:00GlobeNewswire Inc.Avadel Pharmaceuticals to Present at Upcoming Investor ConferencesNASDAQ:AVDLAvadel Pharmaceuticals PLC
2024/05/2221:00GlobeNewswire Inc.Avadel Pharmaceuticals Shares New LUMRYZ™ (sodium oxybate) For Extended-release Oral Suspension (CIII) Data at SLEEP 2024NASDAQ:AVDLAvadel Pharmaceuticals PLC
2024/05/2206:29Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AVDLAvadel Pharmaceuticals PLC
2024/05/2206:27Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:AVDLAvadel Pharmaceuticals PLC
2024/05/2120:04Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:AVDLAvadel Pharmaceuticals PLC
2024/05/2120:00GlobeNewswire Inc.Avadel Pharmaceuticals Appoints Naseem Amin, M.D. to its Board of DirectorsNASDAQ:AVDLAvadel Pharmaceuticals PLC
2024/05/1805:18Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:AVDLAvadel Pharmaceuticals PLC
2024/05/0905:17Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:AVDLAvadel Pharmaceuticals PLC
2024/05/0905:06Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:AVDLAvadel Pharmaceuticals PLC
2024/05/0822:16Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:AVDLAvadel Pharmaceuticals PLC
2024/05/0821:29IH Market NewsU.S. Futures Slightly Dip Amid Corporate Earnings and Quiet Economic Calendar, Oil Prices FallNASDAQ:AVDLAvadel Pharmaceuticals PLC
2024/05/0820:08Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:AVDLAvadel Pharmaceuticals PLC
2024/05/0820:00GlobeNewswire Inc.Avadel Pharmaceuticals Provides Corporate Update and Reports First Quarter 2024 Financial ResultsNASDAQ:AVDLAvadel Pharmaceuticals PLC
 검색 관련기사 보기:NASDAQ:AVDL